$10.7 Billion is the total value of HERSHEY TRUST CO's 37 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 34.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HERSHEY COMPANY CLASS B | $10,557,400,000 | +10.1% | 60,612,012 | 0.0% | 99.00% | -0.1% | ||
| XLI | MFC SELECT SECTOR SPDR TR INDL | $18,842,000 | +4.0% | 184,000 | 0.0% | 0.18% | -5.3% | |
| IYT | Buy | MFC ISHARES TR U S TRANSN ETF | $18,362,000 | +1.2% | 70,635 | +0.3% | 0.17% | -8.5% |
| XLB | MFC SELECT SECTOR SPDR TR SHS | $18,108,000 | +4.5% | 220,000 | 0.0% | 0.17% | -5.0% | |
| SCZ | Buy | MFC ISHARES TR MSCI EAFE SMALL | $15,054,000 | +852.8% | 203,000 | +822.7% | 0.14% | +781.2% |
| HSY | HERSHEY COMPANY COM STK USD1 | $8,216,000 | +10.1% | 47,170 | 0.0% | 0.08% | 0.0% | |
| New | MEITUAN DIANPING USD0.00001 (A | $5,488,000 | – | 133,020 | +100.0% | 0.05% | – | |
| CRSP | Buy | CRISPR THERAPEUTICS AG COM CHF | $3,970,000 | +93.0% | 24,524 | +45.3% | 0.04% | +76.2% |
| PDD | New | ADR PINDUODUO INC SPONSORED AD | $2,785,000 | – | 21,923 | +100.0% | 0.03% | – |
| QUAL | MFC ISHARES MSCI USA | $2,528,000 | +9.1% | 19,026 | 0.0% | 0.02% | 0.0% | |
| RLAY | RELAY THERAPEUTICS INC COM | $2,172,000 | +5.8% | 59,360 | 0.0% | 0.02% | -4.8% | |
| TDOC | Buy | TELADOC HEALTH INC | $2,122,000 | +535.3% | 12,758 | +594.1% | 0.02% | +566.7% |
| IWM | Sell | MFC ISHARES TR RUSSELL 2000 ET | $1,996,000 | -56.4% | 8,700 | -58.0% | 0.02% | -59.6% |
| EEM | MFC ISHARES TR MSCI EMERGING M | $1,277,000 | +3.4% | 23,150 | 0.0% | 0.01% | -7.7% | |
| NARI | INARI MED INC COM | $799,000 | -12.8% | 8,564 | 0.0% | 0.01% | -22.2% | |
| RPTX | Sell | REPARE THERAPEUTICS INC COM | $771,000 | -15.0% | 24,728 | -16.3% | 0.01% | -22.2% |
| MSFT | MICROSOFT CORP COM | $615,000 | +14.7% | 2,272 | 0.0% | 0.01% | 0.0% | |
| BLI | Sell | BERKELEY LTS INC COM | $409,000 | -32.4% | 9,120 | -24.3% | 0.00% | -33.3% |
| CRWD | Buy | CROWDSTRIKE HLDGS INC CL A CL | $393,000 | +65.1% | 1,563 | +19.9% | 0.00% | +100.0% |
| AI | Buy | C3 AI INC CL A CL A | $417,000 | +136.9% | 6,667 | +150.0% | 0.00% | +100.0% |
| EB | EVENTBRITE INC COM CL A | $330,000 | -14.1% | 17,343 | 0.0% | 0.00% | -25.0% | |
| CRNX | CRINETICS PHARMACEUTICALS INC | $373,000 | +23.5% | 19,778 | 0.0% | 0.00% | 0.0% | |
| MOMO | MOMO INC ADR | $306,000 | +3.7% | 19,998 | 0.0% | 0.00% | 0.0% | |
| PACB | PACIFIC BIOSCIENCES OF CALIFOR | $184,000 | +5.1% | 5,258 | 0.0% | 0.00% | 0.0% | |
| NRIX | New | NURIX THERAPEUTICS INC COM | $234,000 | – | 8,807 | +100.0% | 0.00% | – |
| PMVP | PMV PHARMACEUTICALS INC COM | $263,000 | +4.0% | 7,692 | 0.0% | 0.00% | -33.3% | |
| EGRX | EAGLE PHARMACEUTICALS INC COM | $92,000 | +3.4% | 2,138 | 0.0% | 0.00% | 0.0% | |
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $156,000 | -49.8% | 12,836 | 0.0% | 0.00% | -66.7% | |
| JNCE | Buy | JOUNCE THERAPEUTICS INC. COM | $149,000 | +46.1% | 21,948 | +121.9% | 0.00% | 0.0% |
| New | JW THERAPEUTICS HKSE COM | $81,000 | – | 25,113 | +100.0% | 0.00% | – | |
| OYST | OYSTER PT PHARMA INC COM | $152,000 | -6.2% | 8,861 | 0.0% | 0.00% | -50.0% | |
| ALGS | New | ALIGOS THERAPEUTICS INC COM | $124,000 | – | 6,063 | +100.0% | 0.00% | – |
| New | CHINA RENAISSANCE | $125,000 | – | 41,286 | +100.0% | 0.00% | – | |
| APRE | APREA THERAPEUTICS INC COM | $48,000 | -4.0% | 9,822 | 0.0% | 0.00% | -100.0% | |
| MRO | Exit | Marathon Oil Corp | $0 | – | -134 | -100.0% | 0.00% | – |
| NOAH | ADR NOAH HLDGS LTD SPONSORED A | $12,000 | +9.1% | 253 | 0.0% | 0.00% | – | |
| ADVM | ADVERUM BIOTECHNOLOGIES INC CO | $13,000 | -64.9% | 3,710 | 0.0% | 0.00% | – | |
| New | EVERGRANDE PPTY COMMON STOCK | $48,000 | – | 38,079 | +100.0% | 0.00% | – | |
| GKOS | Exit | GLAUKOS CORP | $0 | – | -983 | -100.0% | -0.00% | – |
| LMND | Exit | LEMONADE INC | $0 | – | -9,596 | -100.0% | -0.01% | – |
| W | Exit | WAYFAIR INC CL A | $0 | – | -4,203 | -100.0% | -0.01% | – |
| BIGC | Exit | BIGCOMMERCE HLDGS INC | $0 | – | -22,766 | -100.0% | -0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HERSHEY COMPANY (THE) - CLASS B | 42 | Q3 2023 | 99.9% |
| HERSHEY COMPANY COM STK USD1 | 39 | Q3 2023 | 17.4% |
| Marathon Oil Corp | 26 | Q1 2021 | 0.0% |
| ADR NOAH HOLDINGS LTD | 20 | Q2 2021 | 0.0% |
| ADR VIPSHOP HLDGS LTD SPONSORED | 17 | Q4 2017 | 0.0% |
| EAGLE PHARMACEUTICALS INC COM | 17 | Q2 2021 | 0.0% |
| MOMO INC ADR | 16 | Q2 2021 | 0.0% |
| CRISPR THERAPEUTICS AG COM CHF | 13 | Q3 2023 | 0.0% |
| ZENDESK INC | 13 | Q3 2017 | 0.0% |
| MICROSOFT CORP COM | 11 | Q4 2022 | 0.0% |
View HERSHEY TRUST CO's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2022-11-15 |
| 4 | 2022-11-10 |
| 13F-HR | 2022-08-15 |
View HERSHEY TRUST CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.